An open-label study to evaluate the inflammatory markers in adult patients with asthma associated with allergic rhinitis receiving montelukast therapy.
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic rhinitis; Asthma
- Focus Biomarker; Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 31 Aug 2018 Biomarkers information updated
- 01 Feb 2007 Status changed from recruiting.
- 12 Dec 2006 New trial record.